MERRIMACK PHARMACEUTICALS IN's ticker is and the CUSIP is 590328AA8. A total of 21 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $18,856,000 | +1.9% | 12,522,000 | 0.0% | 2.19% | +60.8% |
| Q4 2015 | $18,501,000 | -1.2% | 12,522,000 | +4.9% | 1.36% | +42.9% |
| Q3 2015 | $18,727,000 | -18.5% | 11,932,000 | +9.1% | 0.95% | +13.7% |
| Q2 2015 | $22,968,000 | +5.0% | 10,932,000 | 0.0% | 0.84% | -29.4% |
| Q1 2015 | $21,880,000 | -3.2% | 10,932,000 | -8.4% | 1.19% | -2.6% |
| Q4 2014 | $22,592,000 | +22.1% | 11,932,000 | 0.0% | 1.22% | +91.7% |
| Q3 2014 | $18,510,000 | +15.0% | 11,932,000 | 0.0% | 0.64% | +53.6% |
| Q2 2014 | $16,093,000 | +18.5% | 11,932,000 | -9.9% | 0.41% | -26.1% |
| Q1 2014 | $13,577,000 | -15.1% | 13,250,000 | -13.1% | 0.56% | -36.5% |
| Q4 2013 | $15,987,000 | +133.9% | 15,250,000 | +103.3% | 0.88% | +102.3% |
| Q3 2013 | $6,835,000 | – | 7,500,000 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FBR & Co. | 1,000,000 | $1,033,000 | 1.76% |
| BASSO CAPITAL MANAGEMENT, L.P. | 5,000,000 | $5,210,000 | 1.04% |
| ARISTEIA CAPITAL, L.L.C. | 15,250,000 | $15,987,000 | 0.88% |
| DINSMORE CAPITAL MANAGEMENT CO/NJ | 1,000,000 | $1,038,000 | 0.42% |
| SILVERBACK ASSET MANAGEMENT LLC | 4,000,000 | $4,200,000 | 0.36% |
| Verition Fund Management LLC | 1,400,000 | $1,472,000 | 0.26% |
| WOLVERINE ASSET MANAGEMENT LLC | 12,500,000 | $13,125,000 | 0.26% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 10,000,000 | $10,407,000,000 | 0.19% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 10,863,000 | $11,361,000 | 0.14% |
| CSS LLC/IL | 2,690,000 | $2,828,000 | 0.14% |